Solara Active Pharma Sciences Limited — Financials & Forensics
NSE: SOLARA · BSE: 541540 · ISIN: INE624Z01016
18 Aug 2026
Add SOLARA to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,268 Cr | ₹1,444 Cr | ₹1,289 Cr | ₹1,284 Cr | ₹1,369 Cr |
| EBITDA | ₹80 Cr | ₹134 Cr | ₹-95 Cr | ₹206 Cr | ₹187 Cr |
| EBITDA margin | 6.3% | 9.3% | -7.4% | 16.1% | 13.6% |
| Profit after tax | ₹-58 Cr | ₹-22 Cr | ₹-567 Cr | ₹1 Cr | ₹-7 Cr |
Deeper analysis
Recent filings by Solara Active Pharma Sciences Limited
-
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity s
18 Aug 2026 · Insider Trading
-
Transcript of Earnings Conference call pertaining to financial results of the Company for the quarte
29 Jul 2026 · Financial Results
-
Solara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publ
24 Jul 2026 · Financial Results
-
Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Read
24 Jul 2026 · Financial Results
-
Solara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1
23 Jul 2026 · General Update
Never miss a filing again
About Solara Active Pharma Sciences Limited on Indian Stock Alerts
Indian Stock Alerts tracks Solara Active Pharma Sciences Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.